BioCardia (BCDA) Financial Statements

336 Followers

BioCardia Financial Overview

BioCardia's market cap is currently $13.24M. The company's EPS TTM is $0; its P/E ratio is -1.01; BioCardia is scheduled to report earnings on March 24, 2026, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 0.00	$ 58.00K	$ 477.00K	$ 1.35M	$ 1.01M
Gross Profit	$ -505.00K	$ -4.33M	$ -7.25M	$ -7.48M	$ 375.00K
Operating Income	$ -8.28M	$ -8.00M	$ -11.64M	$ -11.90M	$ -12.63M
EBITDA	$ -7.77M	$ -7.93M	$ -11.56M	$ -11.82M	$ -12.57M
Net Income	$ -8.23M	$ -7.95M	$ -11.57M	$ -11.91M	$ -12.62M
Balance Sheet
Cash & Short-Term Investments	$ 2.50M	$ 2.37M	$ 1.10M	$ 7.36M	$ 12.87M
Total Assets	$ 3.41M	$ 3.72M	$ 2.99M	$ 9.79M	$ 15.72M
Total Debt	$ 528.00K	$ 951.00K	$ 1.31M	$ 1.63M	$ 1.87M
Net Debt	$ -1.97M	$ -1.42M	$ 212.00K	$ -5.73M	$ -11.00M
Total Liabilities	$ 2.52M	$ 2.89M	$ 4.59M	$ 4.90M	$ 5.34M
Stockholders' Equity	$ 895.00K	$ 837.00K	$ -1.60M	$ 4.89M	$ 10.38M
Cash Flow
Free Cash Flow	$ -7.44M	$ -8.03M	$ -9.99M	$ -10.63M	$ -10.48M
Operating Cash Flow	$ -7.44M	$ -8.03M	$ -9.97M	$ -10.56M	$ -10.37M
Investing Cash Flow	$ -7.00K	$ -6.00K	$ -12.00K	$ -70.00K	$ -116.00K
Financing Cash Flow	$ 7.57M	$ 9.30M	$ 3.73M	$ 5.12M	$ 1.95M

Currency in USD

BioCardia Earnings and Revenue History

Income Statement >

BioCardia Debt to Assets

Balance Sheet >

BioCardia Cash Flow

Cash Flow >

BioCardia Forecast EPS vs Actual EPS

Earnings >